Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Shire Plc Ads (SHPG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,173,016
  • Shares Outstanding, K 303,950
  • Annual Sales, $ 15,161 M
  • Annual Income, $ 4,272 M
  • 36-Month Beta 1.30
  • Price/Sales 3.44
  • Price/Cash Flow 7.56
  • Price/Book 1.39

Price Performance

See More
Period Period Low Period High Performance
1-Month
155.00 +9.43%
on 05/03/18
177.51 -4.45%
on 04/19/18
+7.07 (+4.35%)
since 04/18/18
3-Month
124.73 +35.98%
on 02/21/18
177.51 -4.45%
on 04/19/18
+35.55 (+26.52%)
since 02/16/18
52-Week
123.73 +37.08%
on 02/09/18
190.37 -10.91%
on 05/22/17
-20.39 (-10.73%)
since 05/18/17

Most Recent Stories

More News
Should First Trust NASDAQ-100 Equal Weighted Index Fund (QQEW) Be on Your Investing Radar?

Style Box ETF report for QQEW

QQQ : 167.46 (-0.52%)
ULTA : 255.59 (-0.78%)
QQEW : 59.96 (-0.37%)
HSIC : 71.94 (-0.47%)
IWF : 141.58 (-0.01%)
SHPG : 169.61 (-1.19%)
Nektar (NKTR) Q1 Loss Wider Than Expected, Sales Soar Y/Y

Nektar (NKTR) reports wider-than-expected loss in Q1 while revenues rise substantially year over year. It collaborates with Bristol-Myers for advancing immuno-oncology and immunology pipeline.

LLY : 82.07 (+0.50%)
SHPG : 169.61 (-1.19%)
BMY : 52.71 (-0.06%)
NKTR : 85.30 (+7.66%)
Is First Trust NASDAQ-100 Equal Weighted Index Fund (QQEW) a Hot ETF Right Now?

Smart Beta ETF report for QQEW

QQQ : 167.46 (-0.52%)
ULTA : 255.59 (-0.78%)
QQEW : 59.96 (-0.37%)
HSIC : 71.94 (-0.47%)
IWF : 141.58 (-0.01%)
SHPG : 169.61 (-1.19%)
Caladrius Biosciences Reports 2018 First Quarter Financial Results

Caladrius Biosciences, Inc. (Nasdaq:CLBS) ("Caladrius" or the "Company"), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiovascular...

CLBS : 4.25 (+0.95%)
SHPG : 169.61 (-1.19%)
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Shire plc And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

SHPG : 169.61 (-1.19%)
Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1

Merrimack (MACK) reports wider-than-expected loss in the first quarter.

PTGX : 6.00 (+0.17%)
LGND : 194.99 (+2.01%)
SHPG : 169.61 (-1.19%)
MACK : 8.76 (-0.79%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Shire plc to Takeda Pharmaceutical Company Limited is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

TKPYY : 20.9700 (-1.55%)
SHPG : 169.61 (-1.19%)
Proposed Acquisition of Shire plc by Takeda

--- Better positions Takeda to deliver highly-innovative medicines and transformative care globally -

SHPG : 169.61 (-1.19%)
Athenahealth, Exxon rise; Cognizant, Dentsply fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:

SYY : 63.54 (-0.50%)
XOM : 81.30 (-0.71%)
SHP.LS : 4,199.000 (-0.45%)
ATHN : 150.01 (+0.39%)
IFF : 126.36 (+1.03%)
CTSH : 76.04 (+0.34%)
SHPG : 169.61 (-1.19%)
GPT : 27.51 (-0.07%)
XRAY : 47.50 (-0.94%)
LCS Group Sues Pharma Giant Shire for Breach of Contract & Fraud in Patent Dispute, Potential Damages "Into the Billions"

LCS Group, LLC ("LCS") announced today that it has filed a federal lawsuit in the Southern District of New York against Shire Plc, Shire Development LLC, and Shire LLC ("Shire") alleging...

SHPG : 169.61 (-1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SHPG with:

Business Summary

Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)

See More

Key Turning Points

2nd Resistance Point 171.26
1st Resistance Point 170.43
Last Price 169.61
1st Support Level 168.94
2nd Support Level 168.28

See More

52-Week High 190.37
Last Price 169.61
Fibonacci 61.8% 164.91
Fibonacci 50% 157.05
Fibonacci 38.2% 149.19
52-Week Low 123.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar